Effect of oral magnesium oxide versus placebo on pain due to hysterosalpingography among infertile women

Effect of oral magnesium oxide versus placebo on pain due to hysterosalpingography among infertile women: a double-blind randomized clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120215009014N585

Enrollment

Registered

2025-11-06

Start date

2025-11-16

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female infertility. Female infertility

Interventions

Intervention 1: Intervention group: Routine care before hysterosalpingography followed by intramuscular injection of 1 gram of acetaminophen as a single dose plus four 200 mg magnesium oxide tablet as

Eligibility

Sex/Gender

Female

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Age 20 to 45 years, Infertility, Indication for hysterosalpingography, Weight under 70 kg, Routine menstrual pain intensity between 5 and 8 on a visual analog scale,

Exclusion criteria

Exclusion criteria: Sensitivity to magnesium, Use of anticoagulant drugs, Renal or liver failure,

Design outcomes

Primary

Measure	Time frame
Mean pain score. Timepoint: One hour before the intervention and 1, 2, 3, and 4 hours after. Method of measurement: Using the visual analog scale (VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParham Saberi

Islamic Azad University

Saberi_parham@yahoo.com+98 21 2660 2642

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026